This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mallinckrodt PLC (MNK)

NYSE: Health Care

$64.83 +4.10 | 6.80%
05/03/16 - 3:59:58 PM ET (BATS BZX Real-time Price)
  • Prev Close: 60.71
  • Day's Open: 67.49
  • Volume: 5.55M
  • Avg Vol: 2.81M
  • Shares Outstanding: 111.91M
  • Mkt Cap: 7.00B
  • Div: --
  • Div Yield: --
  • P/E: 21.63
  • EPS: 2.80
MNK Day's Range
$63.47
$68.40
MNK 52 Week Range
$50.90
$132.60
Trade Now:
MNK Business Summary
Mallinckrodt public limited company develops, manufactures, markets, and distributes specialty pharmaceutical and biopharmaceutical products, and nuclear imaging agents in the United States, Europe, the Middle East, Africa, and internationally.View MNK key stats
Mallinckrodt PLC - MNK - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Mallinckrodt PLC as a Hold with a ratings score of C.
Report Snippet: We rate MALLINCKRODT PLC (MNK) a HOLD. The primary factors that have impacted our rating are mixed – some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and generally higher debt management risk.
Rating: 2.67 out of 5, 'C' Hold.
You can view the full analysis from the report here:
MNK Rating Report
MNK Earnings Transcripts
  • Mallinckrodt (MNK) Earnings Report: Q4 2015 Conference Call Transcript
    TheStreet | 02/15/16 - 07:11 PM EST
  • Mallinckrodt (MNK) Earnings Report: Q4 2015 Conference Call Transcript
    TheStreet | 11/24/15 - 07:42 AM EST
  • Mallinckrodt (MNK) Earnings Report: Q3 2015 Conference Call Transcript
    TheStreet | 08/04/15 - 01:13 PM EDT
  • Mallinckrodt (MNK) Earnings Report: Q2 2015 Conference Call Transcript
    TheStreet | 05/06/15 - 11:06 AM EDT
MNK Performance as of Prev. Close
YTD
-18.65%
3-Mo
-7.61%
1-Yr
-46.84%
3-Yr
0.00%
MNK EPS Performance
1-Yr Ago
2.80
2-Yrs Ago
-4.90
3-Yrs Ago
1.00
MNK News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

MNK Mallinckrodt PLC

Chart of MNK

Analysts Ratings for MNK

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 10 10 10 9
Moderate Buy 1 1 1 1
Hold 1 1 1 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET MNK ANALYST REPORT

MNK Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs